People aged under 60 who have been given a first dose of the Oxford-AstraZeneca coronavirus vaccine in Germany will receive a different jab for their second […]
Despite early confusion over efficacy and the initial paucity of data in older age groups,1 the Oxford-AstraZeneca vaccine (ChAdOx1) has been shown to be highly effective, […]
Covid-19 has widened longstanding health and socioeconomic inequalities affecting women and children. The effects will be seen for many years because the wellbeing of women and […]